Drägerwerk AG & Co. KGaA (DRW3)

BRIEF

published on 03/07/2024 at 07:35, 8 months 16 days ago

Drägerwerk AG & Co. KGaA Announces Significant Growth in Fiscal Year 2023

Dividend Increase Annual Report Fiscal Year 2023 Financial Growth Drägerwerk
PRESS RELEASE

published on 03/07/2024 at 07:30, 8 months 16 days ago

Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and profit in fiscal year 2023 and pays significantly higher dividend
Drägerwerk AG & Co. KGaA significantly increases net sales by 13% and profit, pays higher dividend. EBIT at EUR 166 million. Forecasting 1-5% increase in net sales for 2024

Net Sales Dividend Forecast Profit Drägerwerk AG & Co. KGaA
PRESS RELEASE

published on 11/02/2023 at 07:30, 1 year ago

Drägerwerk AG & Co. KGaA: Dräger significantly increases net sales and earnings in the first nine months of 2023
PRESS RELEASE

published on 10/16/2023 at 19:48, 1 year 1 month ago

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q3 2023: Significant increase in earnings – full-year forecast raised
PRESS RELEASE

published on 10/02/2023 at 18:00, 1 year 1 month ago

Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission
PRESS RELEASE

published on 07/27/2023 at 07:30, 1 year 3 months ago

Drägerwerk AG & Co. KGaA: Dräger with significant increase in net sales and earnings in the first half of 2023
PRESS RELEASE

published on 07/14/2023 at 18:29, 1 year 4 months ago

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures H1 2023: Net sales and earnings significantly above prior year – full-year guidance reaffirmed
PRESS RELEASE

published on 05/05/2023 at 16:18, 1 year 6 months ago

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Correction of a prior-year figure in the ad-hoc notification dated April 17, 2023. All other content unchanged.
PRESS RELEASE

published on 05/05/2023 at 16:07, 1 year 6 months ago

Drägerwerk AG & Co. KGaA: Dräger's Annual General Meeting approves stable dividend for fiscal year 2022
PRESS RELEASE

published on 04/28/2023 at 07:30, 1 year 6 months ago

Drägerwerk AG & Co. KGaA: Dräger with strong net sales growth and positive earnings in the first quarter of 2023

Published on 11/22/2024 at 23:55, 1 day 1 hour ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 1 day 1 hour ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 1 day 2 hours ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 1 day 2 hours ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 1 day 2 hours ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 1 day 7 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 1 day 7 hours ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 1 day 7 hours ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 1 day 8 hours ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 1 day 9 hours ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 1 day 10 hours ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 18 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 3 days 6 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 3 days 7 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 3 days 7 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News